Clinical trials
Cardiogenic Shock clinical trials
Below are recruiting cardiogenic shock clinical trials, each written for real people, not researchers. We’re tracking 83 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07027202Recruiting
Early heart unloading for severe shock after ECMO
This trial tests a possible treatment to help the heart recover faster in people who need ECMO support for severe cardiogenic shock (when the heart can't pump enough blood). The treatment involves early use of a device to reduce pressure on the heart's main pumping chamber.
Clermont-FerrandAges 18 years+ - NCT07714746RecruitingPhase 3
Ivabradine for treating cardiogenic shock after heart attack
This trial tests if ivabradine, a drug that lowers heart rate, can help patients in cardiogenic shock after a type of heart attack called STEMI. It is for patients with a fast heart rate (at least 100 beats per minute) who cannot take beta-blockers.
KarachiAges 18–75 - NCT07293923Recruiting
Magenta Elevate™ study for cardiogenic shock
This trial tests a new heart pump called the Magenta Elevate™ to help people whose heart suddenly stops pumping enough blood (cardiogenic shock). It aims to improve blood flow and reduce strain on the heart.
TbilisiAges 40–89 - NCT04020263RecruitingPhase 3
Levosimendan early treatment vs placebo for cardiogenic shock
This study tests whether giving levosimendan early (a heart-strengthening medicine) improves outcomes compared with placebo, on top of standard inotropic support, in people with cardiogenic shock. It mainly looks at whether patients have fewer serious complications or deaths.
Strasbourg, Bas-RhinAges 18 years+ - NCT05185492Recruiting
Registry for treatment outcomes in cardiogenic shock
This trial is a registry that collects information about people with cardiogenic shock to better understand outcomes and improve management. It may help by contributing real-world data on what treatments and timing work best for different heart-related shock causes.
Weston, FloridaAges 18 years+ - NCT05267886RecruitingPhase 4
Testing an inotrope medicine versus placebo in shock patients
This trial studies whether an inotrope medicine (a drug that helps the heart pump) works better than a placebo in adults in intensive care with cardiogenic shock. It may help doctors find safer, more effective treatment for this life-threatening condition.
Rochester, MinnesotaAges 18 years+ - NCT05298124Recruiting
Repairing a leaking mitral valve in severe heart shock
This trial tests a catheter-based procedure to repair a leaking mitral valve in people who are in severe heart shock and need medication support. The goal is to reduce the valve leak and see if it helps patients stabilize and recover.
Rochester, MinnesotaAges 18 years+ - NCT05465200Recruiting
Study for cardiogenic shock treatment in adults under 24 hours
This trial is testing a treatment approach for adults with cardiogenic shock, a life-threatening condition where the heart can’t pump enough blood. You may be considered if your shock started within the last 24 hours and you meet other safety criteria.
WroclawAges 18–60 - NCT05728359Recruiting
Genetic study of outcomes in cardiogenic shock
This study looks at whether a person’s genetic information (genomics) can help predict outcomes in cardiogenic shock. You may be asked to give consent and provide information during a serious heart-related emergency, usually soon after symptoms start.
LondonAges 18–80 - NCT06127927Recruiting
Heart pump for severe heart failure
This trial is testing a temporary heart pump device that helps your heart pump blood when it's too weak to do its job. It's for people who have severe heart failure (cardiogenic shock) despite getting powerful medications to keep their heart working.
Fuzhou, FujianAges 18–75 - NCT06692855Recruiting
Frailty score's role in predicting outcomes for cardiogenic shock
This study looks at whether a simple frailty score (measuring how well someone can function) can help predict recovery for people hospitalized with cardiogenic shock, a condition where the heart suddenly can't pump enough blood.
StrasbourgAges 18 years+ - NCT06697093Recruiting
Polish registry for cardiogenic shock patients
This trial is a registry that collects information on diagnosis, treatment, and outcomes for people with cardiogenic shock (when the heart can't pump enough blood to the body). It may help doctors learn more about this condition and how to treat it better.
Wroclaw, Lower Silesian VoivodeshipAges 18 years+ - NCT06827314Recruiting
Treating cardiogenic shock with drug and mechanical support
This trial is testing different approaches (medications and mechanical support) to help people with acute heart failure and cardiogenic shock (a sudden drop in the heart's pumping ability). It looks at how well these treatments work in a network of hospitals to improve outcomes.
Bologna, BolognaAges 18 years+ - NCT07062744Recruiting
Swan-Ganz catheter for cardiogenic shock after heart attack
This study tests whether a special catheter (Swan-Ganz) placed in the heart's blood vessels helps doctors better manage fluids and medications for people in cardiogenic shock after a heart attack. It aims to improve blood flow to vital organs.
HanoiAges 18 years+ - NCT07085221Recruiting
Remote monitoring for early cardiogenic shock recovery
This trial tests whether digital out-of-hospital management improves outcomes for patients who have recovered from early-stage cardiogenic shock. If you have been discharged after treatment for this condition and can use a smartphone, you may be eligible.
Wuhan, HubeiAges 18 years+ - NCT07266675Recruiting
Recovery after cardiogenic shock study
This trial looks at what happens to people after they survive a serious heart condition called cardiogenic shock, where the heart suddenly can't pump enough blood. Researchers want to understand recovery and improve care for survivors.
TaipeiAges 18 years+ - NCT07309029Recruiting
ECMO support during high-risk TAVR heart valve procedure
This trial tests whether placing patients on ECMO (a heart-lung support machine) before a high-risk TAVR valve replacement can improve safety and outcomes. It is for people who are at very high risk due to low blood pressure, severe heart or lung problems, or complex valve anatomy.
Detroit, MichiganAges 18–100 - NCT07345559Recruiting
Personalized blood pressure targets for cardiogenic shock
This trial tests whether setting a personalized blood pressure goal for each person in cardiogenic shock improves recovery compared to standard care. It may help if you have severe shock and can be enrolled within the first 24 hours.
AmiensAges 18 years+ - NCT07354568Recruiting
Mixed heart and blood vessel shock study
This study looks at people with a severe type of shock that affects both the heart and blood vessels, treated in the intensive care unit. It aims to understand how these patients recover and what factors impact their survival.
Amiens, SommeAges 18 years+ - NCT03313687Recruiting
Safety and outcomes of modern treatments for shock
This study looks at how safe and effective current treatments are for people who have cardiogenic shock, a serious condition when the heart cannot pump enough blood. It mainly aims to understand outcomes from treatment in a hospital setting, which may help improve care for future patients.
HamburgAges 18 years+ - NCT03378739Recruiting
Registry study for cardiogenic shock care at Inova
This study collects information about how cardiogenic shock is treated in the hospital at Inova (for sudden worsening heart failure or a heart attack). It may help improve care for future patients, because the research team will learn what treatments and outcomes are associated with different situations.
Falls Church, VirginiaAges 18–85 - NCT07597291Recruiting
Understanding heart failure shock outcomes and treatments
This registry tracks patients experiencing cardiogenic shock—a serious condition where the heart suddenly cannot pump enough blood to the body. Researchers collect information about patient outcomes and treatments to better understand what helps people recover.
Carnaxide, Lisbon DistrictAges 18 years+ - NCT07090382Enrolling by invitation
Predicting shock risk in heart attack patients
This study uses an AI tool to predict which patients with a heart attack might develop cardiogenic shock, a serious complication where the heart can't pump enough blood. It aims to help doctors identify high-risk patients early.
BratislavaAges 18 years+ - NCT06964685Recruiting
Impella heart pump in heart attack with shock
This study looks at how well the Impella CP heart pump works for people who have a severe heart attack that causes their heart to pump too weakly to keep blood flowing to their body. It's a registry that follows your care to improve best practices.
Jonesboro, ArkansasAges 18 years+
Hear when a new Cardiogenic Shock trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Cardiogenic Shock trials by city
Studies with a site in or near these metro areas.
Cardiogenic Shock trials by state
Studies with a site anywhere in these states.
Common questions
- Are there clinical trials for cardiogenic shock?
- Yes. Clin2 currently lists 83 recruiting cardiogenic shock studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a cardiogenic shock trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a cardiogenic shock trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.